14 research outputs found
Partnerships for Transformation towards Sustainable Pathways : Research and Innovation Collaboration between Finland and Africa, Asia, and Latin America and the Caribbean for the SDGs
As highlighted in the PATH2030 – An Evaluation of Finland’s Sustainable Development Policy, Finland has made significant progress towards achieving the SDGs nationally – though not without its own weaknesses and challenges. However, for the country to become a global leader in addressing the SDGs, greater emphasis must be placed on policy coherence, resourcing, and utilizing research data for decision-making.Non peer reviewe
Reconciliation in Rwanda : perspectives from the parliament
The purpose of this thesis is to examine the meaning of political reconciliation in Rwanda and the ways this is expressed. Thus, Rwandan Senators were interviewed to understand their interpretations of reconciliation in Rwanda. Furthermore, it seeks to understand the tools of reconciliation used in Rwanda and how Senators feel these contribute to the reconciliation process. This study attempts to understand the political through the personal.
Political reconciliation is approached by analyzing and applying Andrew Schaap’s concept of political reconciliation and Carl Schmitt’s concept of the political.
The research material was collected in Rwanda by interviewing 12 Senators in the Rwandan Parliament. Of the 12 interviews conducted, 8 are used in this study. Qualitative interviewing was used, with a semistructured interview format.
The study found that the Rwandan concept of political reconciliation is an attempt to reformulate the primary political identification from an ethnic one to a national one. It also finds that this is attempting to be done through the creation of a shared national experience, which the gacaca process highlights
Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs
The formation of undesired high molecular weight species such as dimers is an important quality attribute for therapeutic monoclonal antibody formulations. Therefore, the thorough understanding of mAb dimerization and the detailed characterization mAb dimers is of great interest for future pharmaceutical development of therapeutic antibodies. In this work, we focused on the analyses of different mAb dimers regarding size, surface properties, chemical identity, overall structure and localization of possible dimerization sites. Dimer fractions of different mAbs were isolated to a satisfactory purity from bulk material and revealed two predominant overall structures, namely elongated and compact dimer forms. The elongated dimers displayed one dimerization site involving the tip of the Fab domain. Depending on the stress applied, these elongated dimers are connected either covalently or non-covalently. In contrast, the compact dimers exhibited non-covalent association. Several interaction points were detected for the compact dimers involving the hinge region or the base of the Fab domain. These results indicate that mAb dimer fractions are rather complex and may contain more than one kind of dimer. Nevertheless, the overall appearance of mAb dimers suggests the existence of two predominant dimeric structures, elongated and compact, which are commonly present in preparations of therapeutic mAbs
Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs
The formation of undesired high molecular weight species such as dimers is an important quality attribute for therapeutic monoclonal antibody formulations. Therefore, the thorough understanding of mAb dimerization and the detailed characterization mAb dimers is of great interest for future pharmaceutical development of therapeutic antibodies. In this work, we focused on the analyses of different mAb dimers regarding size, surface properties, chemical identity, overall structure and localization of possible dimerization sites. Dimer fractions of different mAbs were isolated to a satisfactory purity from bulk material and revealed 2 predominant overall structures, namely elongated and compact dimer forms. The elongated dimers displayed one dimerization site involving the tip of the Fab domain. Depending on the stress applied, these elongated dimers are connected either covalently or non-covalently. In contrast, the compact dimers exhibited non-covalent association. Several interaction points were detected for the compact dimers involving the hinge region or the base of the Fab domain. These results indicate that mAb dimer fractions are rather complex and may contain more than one kind of dimer. Nevertheless, the overall appearance of mAb dimers suggests the existence of 2 predominant dimeric structures, elongated and compact, which are commonly present in preparations of therapeutic mAbs
A Human Skeletal Muscle Atlas Identifies the Trajectories of Stem and Progenitor Cells across Development and from Human Pluripotent Stem Cells.
The developmental trajectory of human skeletal myogenesis and the transition between progenitor and stem cell states are unclear. We used single-cell RNA sequencing to profile human skeletal muscle tissues from embryonic, fetal, and postnatal stages. In silico, we identified myogenic as well as other cell types and constructed a "roadmap" of human skeletal muscle ontogeny across development. In a similar fashion, we also profiled the heterogeneous cell cultures generated from multiple human pluripotent stem cell (hPSC) myogenic differentiation protocols and mapped hPSC-derived myogenic progenitors to an embryonic-to-fetal transition period. We found differentially enriched biological processes and discovered co-regulated gene networks and transcription factors present at distinct myogenic stages. This work serves as a resource for advancing our knowledge of human myogenesis. It also provides a tool for a better understanding of hPSC-derived myogenic progenitors for translational applications in skeletal muscle-based regenerative medicine
Recommended from our members
A Human Skeletal Muscle Atlas Identifies the Trajectories of Stem and Progenitor Cells across Development and from Human Pluripotent Stem Cells
(Cell Stem Cell 27, 158–176.e1–e10; July 2, 2020) It came to our attention that during revision we updated the tSNE plot for the left panel of Figure 1D but mistakenly did not update the right panel of Figure 1D or Figure S1D. This error on our part does not affect any of the results or conclusions of our paper. The abovementioned figures have now been updated with the correct tSNE coordinates and reproduced below. We apologize for this oversight and any inconvenience the readers might have encountered. [Figure presented] [Formula presented][Formula presented] [Formula presented